Main Article Content


Diclofenac (DCF) is one of the most generally utilized non-steroidal antiinflammatory therapies during the world for different diseases curing in post pubertal ladies. Be that as it may, constrained data is accessible with respect to its security during pregnancy and teratogenicity. The present study was done to investigate the histopathological impact of diclofenac potassium (DP) on some vital maternal and fetal tissues, placenta and liver during two different periods of gestation. In this study 30 pregnant rats have been used and divided into 3 groups (ten for each one); group 1 (control), group 2 treated with 15.4 mg/kg of diclofenac potassium during organogenesis period, and group 3 subjected during fetal developmental period with the same dosage. At the 20 gestation day the rats were anesthetized and dissected, histopathological studies on placenta, maternal liver, and fetal liver have been done. Our results revealed moderate to severe histopathological alternations in all examined tissues like disorganization of tissue architecture, vacuolation, lymphatic infiltration, apoptosis and more changes. There is a harmful effect of the DP on the placenta tissue and also the liver tissue of the fetus, and on this we recommend that you use the DP with caution during pregnancy at the possible lowest effective dose and for the shortest duration.


Diclofenac Potassium Liver Placenta Pregnant Rats

Article Details

How to Cite
Abdel-Rahman Tawfik, Nouf Bader Alduweesh, Zeinab Abdel-Hameid Mohamed, Abdel Rahman Sayed Sultan, & Heba Ali Abd El-Rahman. (2020). The histopathological effect of diclofenac potassium on maternal and fetal tissues. International Journal of Research in Pharmaceutical Sciences, 11(3), 2866-2878.